Ryan Keh

801 total citations
18 papers, 182 citations indexed

About

Ryan Keh is a scholar working on Neurology, Cellular and Molecular Neuroscience and Hematology. According to data from OpenAlex, Ryan Keh has authored 18 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Hematology. Recurrent topics in Ryan Keh's work include Peripheral Neuropathies and Disorders (15 papers), Hereditary Neurological Disorders (7 papers) and Myasthenia Gravis and Thymoma (6 papers). Ryan Keh is often cited by papers focused on Peripheral Neuropathies and Disorders (15 papers), Hereditary Neurological Disorders (7 papers) and Myasthenia Gravis and Thymoma (6 papers). Ryan Keh collaborates with scholars based in United Kingdom, Australia and United States. Ryan Keh's co-authors include James B Lilleker, Laurence Abernethy, Mark Roberts, Reena Sharma, Benedetta Pettorini, Federico Roncaroli, Michael P. Lunn, Simon Rinaldi, Alexander M. Rossor and Timothy Lavin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Cochrane Database of Systematic Reviews.

In The Last Decade

Ryan Keh

16 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan Keh United Kingdom	7	115	84	43	24	22	18	182
Sandrine Larue Canada	6	75 0.7×	60 0.7×	38 0.9×	49 2.0×	21 1.0×	10	176
Cécile Cauquil France	9	69 0.6×	46 0.5×	150 3.5×	29 1.2×	37 1.7×	20	268
Maria Alberti Spain	10	188 1.6×	149 1.8×	44 1.0×	18 0.8×	40 1.8×	20	278
Luciana Cardoso Bonadia Brazil	11	66 0.6×	96 1.1×	110 2.6×	21 0.9×	20 0.9×	24	313
Can Ebru Bekircan‐Kurt Türkiye	10	103 0.9×	33 0.4×	73 1.7×	44 1.8×	7 0.3×	39	233
H. Konishi Japan	5	76 0.7×	81 1.0×	84 2.0×	9 0.4×	10 0.5×	16	212
Donato Sauchelli Italy	6	81 0.7×	31 0.4×	84 2.0×	12 0.5×	4 0.2×	9	195
Marta Lipowska Poland	10	145 1.3×	67 0.8×	56 1.3×	21 0.9×	21 1.0×	24	248
Stephanie Jou United States	8	111 1.0×	99 1.2×	48 1.1×	30 1.3×	13 0.6×	20	260
Katherine S. Elliott United Kingdom	8	95 0.8×	16 0.2×	71 1.7×	10 0.4×	8 0.4×	12	238

Countries citing papers authored by Ryan Keh

Since Specialization

Citations

This map shows the geographic impact of Ryan Keh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Keh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Keh more than expected).

Fields of papers citing papers by Ryan Keh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Keh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Keh. The network helps show where Ryan Keh may publish in the future.

Co-authorship network of co-authors of Ryan Keh

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Keh. A scholar is included among the top collaborators of Ryan Keh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Keh. Ryan Keh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Keh, Ryan, Stephen Keddie, Georgios Baskozos, et al.. (2025). Plasma periaxin is a biomarker of peripheral nerve demyelination. Brain. 148(12). 4448–4460. 3 indexed citations

Dodd, Katherine, Fiona J. Clay, J. Handley, et al.. (2025). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2025(7). CD014574–CD014574. 1 indexed citations

White, Laura M., Fiona J. Clay, Ryan Keh, et al.. (2025). FcRn inhibitors for myasthenia gravis. Cochrane Database of Systematic Reviews. 2025(8). CD016097–CD016097.

Dodd, Katherine, Fiona J. Clay, Ryan Keh, et al.. (2023). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2023(4). 3 indexed citations

Keddie, Stephen, Ryan Keh, Donna Grant, et al.. (2023). Peripherin is a biomarker of axonal damage in peripheral nervous system disease. Brain. 146(11). 4562–4573. 31 indexed citations

Keh, Ryan, James B Lilleker, Tim Lavin, et al.. (2022). Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS). Journal of the Peripheral Nervous System. 27(4). 302–310. 4 indexed citations

Khwaja, Jahanzaib, et al.. (2022). Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome. SHILAP Revista de lepidopterología. 3(3). 1021–1024. 9 indexed citations

Keh, Ryan, et al.. (2022). 105 Broadening the clinical spectrum of bortezimib induced peripheral neuropathy: 4 illustrative cases. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A44.2–A44. 1 indexed citations

D’Sa, Shirley, Jahanzaib Khwaja, Stephen Keddie, et al.. (2022). Comprehensive Diagnosis and Management of POEMS Syndrome. HemaSphere. 6(11). e796–e796. 6 indexed citations

10.

Keh, Ryan, Sachit Shah, James B Lilleker, et al.. (2022). Pragmatic guide to peripheral nerve disease and the role of clinical biomarkers. Practical Neurology. 22(6). 461–471. 3 indexed citations

11.

Kapoor, Mahima, Ryan Keh, Sarah A. Morrow, et al.. (2021). Subcutaneous immunoglobulin dose titration to clinical response in inflammatory neuropathy. Journal of Neurology. 268(4). 1485–1490. 5 indexed citations

12.

Fehmi, Janev, Alexander J. Davies, Timothy Lavin, et al.. (2021). IgG ₁ pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. Journal of Neurology Neurosurgery & Psychiatry. 92(10). 1089–1095. 38 indexed citations

13.

Keh, Ryan, David Gosal, Timothy Lavin, et al.. (2021). Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling. Journal of the Peripheral Nervous System. 27(1). 84–93. 7 indexed citations

14.

Keh, Ryan, Mahima Kapoor, David Gosal, et al.. (2019). Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?. Journal of the Neurological Sciences. 408. 116527–116527. 5 indexed citations

15.

Kemp, Michael, et al.. (2019). 207 An atypical cause of longitudinally extensive transverse myelitis after an allogeneic haemopoietic stem cell transplant. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e52.2–e52.

16.

Keh, Ryan, et al.. (2019). Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre. Transfusion and Apheresis Science. 58(6). 102654–102654. 5 indexed citations

17.

Lilleker, James B, Ryan Keh, Federico Roncaroli, Reena Sharma, & Mark Roberts. (2017). Metabolic myopathies: a practical approach. Practical Neurology. 18(1). 14–26. 38 indexed citations

18.

Keh, Ryan, Laurence Abernethy, & Benedetta Pettorini. (2012). Association between Noonan syndrome and Chiari I malformation: a case-based update. Child s Nervous System. 29(5). 749–752. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact